908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. The company is headquartered in Boston, Massachusetts and currently employs 246 full-time employees. The company went IPO on 2020-12-18. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.
Dr. Kevin Knopp is the President of 908 Devices Inc, joining the firm since 2012.
What is the price performance of MASS stock?
The current price of MASS is $8.29, it has increased 0.85% in the last trading day.
What are the primary business themes or industries for 908 Devices Inc?
908 Devices Inc belongs to Electrical Equipment industry and the sector is Information Technology
What is 908 Devices Inc market cap?
908 Devices Inc's current market cap is $313.4M
Is 908 Devices Inc a buy, sell, or hold?
According to wall street analysts, 4 analysts have made analyst ratings for 908 Devices Inc, including 4 strong buy, 4 buy, 2 hold, 0 sell, and 4 strong sell